Home / Conferences

Conferences

Microbiological control symposium: consensus on readiness of new methods emerges

A symposium on microbiology in the pharmaceutical sector was the opportunity for the European Directorate for the Quality of Medicines & HealthCare (EDQM) to gather feedback from users of the European Pharmacopoeia on alternative testing methods for microbiological control and sterilisation processes. The event, which took place in Strasbourg on 10−11 October 2017, was attended by a wide range of experts in the pharmaceutical and microbiological fields who reviewed the latest trends and innovations in the field of microbiology, in addition to pharmacopoeial approaches and related regulatory requirements.

Medicines for Europe 16th Biosimilar Medicines Conference

16th Biosimilar Medicines Conference – Biosimilar Medicines: Unlocking the Full Potential of Biologics
26−27 April 2018
Grange Tower Bridge Hotel
London, UK

Joint 24th Medicines for Europe and 21st IGBA Annual Conference – Global Generic, Biosimilar and Value Added Medicines Conference

Joint 24th Medicines for Europe and 21st IGBA Annual Conference – Global Generic, Biosimilar and Value Added Medicines Conference
13−15 June 2018
Hilton Budapest Hotel
Budapest
Hungary

DIA 2018 Global Annual Meeting

DIA 2018 Global Annual Meeting
24−28 June 2018 
Boston, MA
USA

ACI 9th Annual Summit on Biosimilars 2018

ACI 9th Annual Summit on Biosimilars 2018
25−27 June 2018
InterContinental New York Times Square
New York, NY
USA

European Pharmacopoeia prepares for the future through exchange with stakeholders

To mark the publication of the 9th edition of the European Pharmacopoeia (Ph. Eur.), the EDQM (European Directorate for the Quality of Medicines) organized a large international conference in Tallinn, Estonia, which brought together representatives of European and international regulatory authorities, the World Health Organization (WHO), pharmacopoeias from different continents as well as industry and associations from Europe and beyond. Participants came from 41 different countries, including Brazil, Canada, India, Japan, South Africa, Taiwan and USA.

Extrapolation key issue at European biosimilars conference

The European Generic medicines Association (EGA) held its 13th EGA-European Biosimilars Group Conference in London on 23–24 April 2015.

French generics association promotes biosimilars

French generics association GEMME held its first symposium on the challenges and opportunities associated with biosimilars in France on 3 October 2014.

Topics presented at the 16th IGPA conference on generics

Topics presented at the 16th Annual IGPA Conference, held in Brussels, Belgium, 9–11 December 2013, showed that despite differences in the pharmaceutical market in different countries most appreciate the value of generics. In most cases this is driven by cost reduction.

EGA pushes for increased focus on generics and biosimilars

EGA President Ms Gudbjorg Edda Eggertsdottir, speaking at the European Generic medicines Association’s (EGA’s) conferences in London, UK (11th EGA International Symposium on Biosimilar Medicines) and in Athens, Greece (19th EGA Annual Conference); stressed the importance of keeping generics and biosimilars manufacturers within Europe, thus ensuring that high quality manufacturing jobs and know-how remains in Europe. This would benefit society and patients and increase the competitiveness and innovative capacity of the pharmaceutical industry in Europe.

Generics News Research General

more

Biosimilars News Research General

more